![]() |
市場調查報告書
商品編碼
2026267
腫瘤資訊學市場規模、佔有率和成長分析:按產品/服務、應用、最終用戶、部署模式、銷售管道和地區分類-2026年至2033年產業預測Oncology Informatics Market Size, Share, and Growth Analysis, By Product and Service (Software, Services), By Application (Medical Oncology, Radiation Oncology), By End-User, By Deployment Mode, By Sales Channel, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球腫瘤資訊學市場價值為 44.2 億美元,預計到 2033 年將從 2025 年的 49.9 億美元成長至 131 億美元,預測期(2026-2033 年)的複合年成長率為 12.8%。
腫瘤資訊學市場的發展動力源於癌症發病率的上升和精準腫瘤學的興起,這需要整合的數據工具來實現個人化治療和有效的護理管理。關鍵組成部分包括電子健康記錄、基因組數據平台、決策支援系統和護理協調工具,這些工具能夠將分散的資訊轉化為可執行的洞察。技術進步強調了互通性和資料整合,從而能夠有效地聚合臨床和基因組數據,並增強用於治療方法選擇和不利事件檢測的機器學習模型。人工智慧的興起透過簡化各種資料類型的處理和改進隊列識別,進一步變革了資料管理。醫療保健系統和診斷公司之間的合作正在加速創新,並推動以價值為導向的醫療模式的發展。
全球腫瘤資訊學市場促進因素
全球腫瘤資訊學市場正受到人工智慧 (AI) 整合的顯著推動,AI 的應用旨在增強數據解讀並改善臨床決策。腫瘤資訊學平台利用 AI 整合各種形式的信息,包括臨床數據、基因組數據和影像數據,並將其轉化為可執行的洞察。這項進步不僅提高了診斷準確性,還簡化了臨床醫生的工作流程,簡化了治療計劃,並增強了醫療團隊的信心。隨著這些功能展現出個人化醫療和多學科診療的實際益處,對能夠支持不同醫療環境中循證腫瘤學實踐的先進軟體的需求日益成長。
全球腫瘤資訊學市場面臨的限制因素
全球腫瘤資訊學市場面臨的挑戰主要源於對患者資料隱私以及高度敏感的臨床和基因組資訊安全性的擔憂。許多醫療機構不願在不同平台和機構之間共用數據,導致其在採用腫瘤資訊解決方案時採取謹慎態度。對資料管治和潛在資料外洩風險的擔憂進一步加劇了這種猶豫,促使各機構推遲實施或限制系統功能以消除這些顧慮。這種猶豫阻礙了對高級分析和協作醫療至關重要的全面資料集的整合,最終阻礙了市場成長,直到信任和強大的安全措施得到牢固建立。
全球腫瘤資訊學市場趨勢
全球腫瘤資訊學市場正經歷著向人工智慧驅動的決策支援系統的顯著轉變,這些系統正在從根本上改變臨床工作流程。這些先進的平台利用模式識別和預測檢驗提供可操作的治療建議,從而提高臨床醫生的工作效率和診斷準確性。隨著對透明度和即時驗證的日益重視,醫療機構正擴大採用能夠無縫整合到現有工作流程中、優先考慮使用者體驗並促進跨學科協作的解決方案。這種演變不僅增強了個人化醫療,也凸顯了持續學習和臨床檢驗的重要性,反映了腫瘤管理正朝著更具策略性和數據驅動的方向發展。
Global Oncology Informatics Market size was valued at USD 4.42 Billion in 2024 and is poised to grow from USD 4.99 Billion in 2025 to USD 13.1 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).
The oncology informatics market is being propelled by the increasing incidence of cancer and the shift towards precision oncology, necessitating integrated data tools for tailored therapies and effective care management. Key components include electronic health records, genomic data platforms, decision support systems, and care coordination tools that transform disparate information into actionable insights. Technological advancements emphasize interoperability and data integration, which allow for the effective aggregation of clinical and genomic data, enhancing machine learning models used for therapy selection and adverse event detection. The rise of AI is further revolutionizing data management by streamlining the handling of varied data types and improving cohort identification. Collaboration among health systems and diagnostic firms is accelerating innovation while promoting value-based care.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Informatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Oncology Informatics Market Segments Analysis
Global oncology informatics market is segmented by product and service, application, end-user, deployment mode, sales channel and region. Based on product and service, the market is segmented into Software, Services and Others. Based on application, the market is segmented into Medical Oncology, Radiation Oncology, Surgical Oncology and Others. Based on end-user, the market is segmented into Hospitals, Oncology Clinics, Research and Academic Centers and Others. Based on deployment mode, the market is segmented into Cloud-Based, On-Premise and Others. Based on sales channel, the market is segmented into Direct Enterprise Sales, Managed Service Providers, Online Healthcare Platforms and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Oncology Informatics Market
The Global Oncology Informatics market is significantly driven by the integration of artificial intelligence, which enhances the interpretation of data and improves clinical decision-making. Oncology informatics platforms leverage AI to synthesize various forms of information, including clinical, genomic, and imaging data, into actionable insights. This advancement not only boosts diagnostic accuracy but also streamlines workflows for clinicians, simplifying treatment planning and instilling confidence in healthcare teams. As these capabilities showcase the tangible benefits of personalized therapies and the coordination of multidisciplinary care, there is an increased demand for advanced software that supports evidence-based oncology practices across varied healthcare environments.
Restraints in the Global Oncology Informatics Market
The advancement of the Global Oncology Informatics market faces challenges primarily due to apprehensions surrounding patient data privacy and the security of sensitive clinical and genomic information. Many healthcare providers are reluctant to share data across various platforms and institutions, resulting in a cautious approach to the adoption of oncology informatics solutions. Concerns about data governance and the risk of potential breaches further contribute to this hesitance, causing organizations to postpone implementation or restrict system capabilities to address these fears. This reluctance hinders the integration of comprehensive datasets, which are essential for advanced analytics and collaborative care, ultimately impeding market growth until trust and robust security measures are firmly established.
Market Trends of the Global Oncology Informatics Market
The Global Oncology Informatics market is experiencing a notable shift toward AI-driven decision support systems, which are significantly transforming clinical workflows. These advanced platforms leverage pattern recognition and predictive analytics to provide actionable treatment recommendations, enhancing clinician efficiency and diagnostic accuracy. With a focus on transparency and real-time validation, healthcare providers are increasingly adopting solutions that seamlessly integrate into existing workflows, prioritize user experience, and foster interdisciplinary collaboration. This evolution not only improves individualized patient care but also emphasizes the importance of continuous learning and clinical validation, reflecting a trend toward more strategic and data-driven approaches in oncology treatment management.